A novel noninvasive index for nonalcoholic steatohepatitis: a pilot study

References

• Angulo P, Hui JM, Marchesini G, et al. (2007). The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD. Hepatology 45:846–54
   PubMed Web of Science ®Google Scholar
• Cales P, Laine F, Boursier J, et al. (2009). Comparison of blood tests for liver fibrosis specific or not to NAFLD. J Hepatol 50:165–73
   PubMed Web of Science ®Google Scholar
• Chalasani N, Younossi Z, Lavine JE, et al. (2012). The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology 55:2005–23
   PubMed Web of Science ®Google Scholar
• Deminice R, Portari GV, Marchini JS, et al. (2009). Effects of a low-protein diet on plasma amino acid and homocysteine levels and oxidative status in rats. Ann Nutr Metab 54:202–7
   Google Scholar
• Fan JG, Jia JD, Li YM, et al. (2011). Guidelines for the diagnosis and management of nonalcoholic fatty liver disease: update 2010: (published in Chinese on Chinese Journal of Hepatology 2010;18:163–166). J Dig Dis 12:38–44
   PubMed Web of Science ®Google Scholar
• Friedewald WT, Levy RI, Fredrickson DS. (1972). Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18:499–502
   PubMed Web of Science ®Google Scholar
• Guha IN, Parkes J, Roderick P, et al. (2008). Noninvasive markers of fibrosis in nonalcoholic fatty liver disease: validating the European Liver Fibrosis Panel and exploring simple markers. Hepatology 47:455–60
   PubMed Web of Science ®Google Scholar
• Guha IN, Parkes J, Roderick PR, et al. (2006). Non-invasive markers associated with liver fibrosis in non-alcoholic fatty liver disease. Gut 55:1650–60
   PubMed Web of Science ®Google Scholar
• Katz A, Nambi SS, Mather K, et al. (2000). Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 85:2402–10
   PubMed Web of Science ®Google Scholar
• Kleiner DE, Brunt EM, Van NM, et al. (2005). Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41:1313–21
   PubMed Web of Science ®Google Scholar
• Kruger FC, Daniels CR, Kidd M, et al. (2011). APRI: a simple bedside marker for advanced fibrosis that can avoid liver biopsy in patients with NAFLD/NASH. S Afr Med J 101:477–80
   PubMed Web of Science ®Google Scholar
• Matthews DR, Hosker JP, Rudenski AS, et al. (1985). Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412–19
   PubMed Web of Science ®Google Scholar
• Miller MH, Ferguson MA, Dillon JF. (2011). Systematic review of performance of non-invasive biomarkers in the evaluation of non-alcoholic fatty liver disease. Liver Int 31:461–73
   PubMed Web of Science ®Google Scholar
• Palekar NA, Naus R, Larson SP, et al. (2006). Clinical model for distinguishing nonalcoholic steatohepatitis from simple steatosis in patients with nonalcoholic fatty liver disease. Liver Int 26:151–6
   PubMed Web of Science ®Google Scholar
• Polyzos SA, Kountouras J, Patsiaoura K, et al. (2012a). Serum homocysteine levels in patients with nonalcoholic fatty liver disease. Ann Hepatol 11:68–76
   PubMed Web of Science ®Google Scholar
• Polyzos SA, Kountouras J, Zavos C. (2009). Nonalcoholic fatty liver disease: the pathogenetic roles of insulin resistance and adipocytokines. Curr Mol Med 72:299–314
   Web of Science ®Google Scholar
• Polyzos SA, Kountouras J, Zavos C, et al. (2012b). Nonalcoholic fatty liver disease: multimodal treatment options for a pathogenetically multiple-hit disease. J Clin Gastroenterol 46:272–84
   PubMed Web of Science ®Google Scholar
• Poynard T, Ratziu V, Charlotte F, et al. (2006). Diagnostic value of biochemical markers (NashTest) for the prediction of non alcoholo steato hepatitis in patients with non-alcoholic fatty liver disease. BMC Gastroenterol 6:34
   PubMed Web of Science ®Google Scholar
• Ratziu V, Bellentani S, Cortez-Pinto H, et al. (2010). A position statement on NAFLD/NASH based on the EASL 2009 special conference. J Hepatol 53:372–84
   PubMed Web of Science ®Google Scholar
• Ratziu V, Charlotte F, Heurtier A, et al. (2005). Sampling variability of liver biopsy in nonalcoholic fatty liver disease. Gastroenterology 128:1898–906
   PubMed Web of Science ®Google Scholar
• Shah AG, Lydecker A, Murray K, et al. (2009). Comparison of noninvasive markers of fibrosis in patients with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol 7:1104–12
   PubMed Web of Science ®Google Scholar
• Shimada M, Kawahara H, Ozaki K, et al. (2007). Usefulness of a combined evaluation of the serum adiponectin level, HOMA-IR, and serum type IV collagen 7S level to predict the early stage of nonalcoholic steatohepatitis. Am J Gastroenterol 102:1931–8
   PubMed Web of Science ®Google Scholar
• Sumida Y, Yoneda M, Hyogo H, et al. (2011). A simple clinical scoring system using ferritin, fasting insulin, and type IV collagen 7S for predicting steatohepatitis in nonalcoholic fatty liver disease. J Gastroenterol 46:257–68
   PubMed Web of Science ®Google Scholar
• Tamimi TI, Elgouhari HM, Alkhouri N, et al. (2011). An apoptosis panel for nonalcoholic steatohepatitis diagnosis. J Hepatol 54:1224–9
   PubMed Web of Science ®Google Scholar
• Vernon G, Baranova A, Younossi ZM. (2011). Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Aliment Pharmacol Ther 34:274–85
   PubMed Web of Science ®Google Scholar
• Younossi ZM, Jarrar M, Nugent C, et al. (2008). A novel diagnostic biomarker panel for obesity-related nonalcoholic steatohepatitis (NASH). Obes Surg 18:1430–7
   PubMed Web of Science ®Google Scholar
• Younossi ZM, Page S, Rafiq N, et al. (2011). A biomarker panel for non-alcoholic steatohepatitis (NASH) and NASH-related fibrosis. Obes Surg 21:431–9
   PubMed Web of Science ®Google Scholar
• Zois CD, Baltayiannis GH, Bekiari A, et al. (2010). Steatosis and steatohepatitis in postmortem material from Northwestern Greece. World J Gastroenterol 16:3944–9
   Google Scholar